Evidence map›Paper›PMID 25955609›Full record

ArticlePloS one2015

Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts.

Mónica del Rey, Rocío Benito, Celia Fontanillo, Francisco J Campos-Laborie, Kamila Janusz, Talía Velasco-Hernández, María Abáigar, María Hernández, Rebeca Cuello, Daniel Borrego and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Leukemia research reports · 2022
    Article
  6. Is Myelodysplasia a Consequence of Normal Aging?Current oncology reports · 2021
    Review
  7. Review
  8. Platelet abnormalities in Huntington's disease.Journal of neurology, neurosurgery, and psychiatry · 2019
    Article
  9. Review
  10. Clinical and genetic aspects of defects in the mitochondrial iron-sulfur cluster synthesis pathway.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2018
    Review
  11. Review
  12. Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.International journal of hematology · 2017
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Mónica del ReyIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Rocío BenitoIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Celia FontanilloIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Francisco J Campos-LaborieIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Kamila JanuszIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Talía Velasco-HernándezInstituto de Biología Funcional y Genómica, CSIC-Universidad de Salamanca, Salamanca, Spain.
María AbáigarIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
María HernándezIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Rebeca CuelloServicio de Hematología, Hospital Clínico de Valladolid, Valladolid, Spain.
Daniel BorregoServicio de Hematología, Hospital Clínico de Valladolid, Valladolid, Spain.
Dionisio Martín-ZancaInstituto de Biología Funcional y Genómica, CSIC-Universidad de Salamanca, Salamanca, Spain.
Javier De Las RivasIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Ken I MillsCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Jesús M Hernández-RivasIBMCC, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-CSIC, Salamanca, Spain; IBSAL, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.
Instituto de Investigación Biomédica de Salamanca · ESCentro de Investigación del Cáncer · ESHospital Clínico Universitario de Valladolid · ESUniversidad de Salamanca · ESQueen's University Belfast · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of SF3B1 gene mutations is a hallmark of refractory anemia with ring sideroblasts (RARS). However, the mechanisms responsible for iron accumulation that characterize the Myelodysplastic Syndrome with ring sideroblasts (MDS-RS) are not completely understood. In order to gain insight in the molecular basis of MDS-RS, an integrative study of the expression and mutational status of genes related to iron and mitochondrial metabolism was carried out. A total of 231 low-risk MDS patients and 81 controls were studied. Gene expression analysis revealed that iron metabolism and mitochondrial function had the highest number of genes deregulated in RARS patients compared to controls and the refractory cytopenias with unilineage dysplasia (RCUD). Thus mitochondrial transporters SLC25 (SLC25A37 and SLC25A38) and ALAD genes were over-expressed in RARS. Moreover, significant differences were observed between patients with SF3B1 mutations and patients without the mutations. The deregulation of genes involved in iron and mitochondrial metabolism provides new insights in our knowledge of MDS-RS. New variants that could be involved in the pathogenesis of these diseases have been identified.

Indexed as

Gene Expression RegulationAnemia, RefractoryAnemia, SideroblasticCation Transport ProteinsDNA Mutational AnalysisGene Expression ProfilingGenetic Predisposition to DiseaseHumansIronMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial ProteinsOligonucleotide Array Sequence AnalysisPhosphoproteinsRibonucleoprotein, U2 Small NuclearRNA Splicing FactorsCation Transport ProteinsIronMitochondrial Membrane Transport ProteinsMitochondrial ProteinsPhosphoproteinsRibonucleoprotein, U2 Small NuclearRNA Splicing FactorsSF3B1 protein, humanSlc25a37 protein, humanSlc25a38 protein, human

Identifiers

PMID25955609
PMCPMC4425562
OpenAlexW1553923096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.